检索

标题
作者
Management of patients with arterial hypertension and atrial fibrillation
Chazova I., Golitsyn S., Zhernakova J., Zheleznova E., Kropacheva E., Mironov N., Kostiukevich M., Laiovich L., Utsumueva M., Iuricheva I., Litvin A., Elfimova E., Rogoza A., Panchenko E.
Knowledge of senior students in the definition, classification, and approaches to the treatment of arterial hypertension. Final results of the PHYSTARH project
Bontsevich R., Vovk Y., Gavrilova A., Batishcheva G., Goncharova N., Elizarova I., Ketova G., Barysheva V., Bikkinina G., Myronenko O.
Drug-induced arterial hypertension
Ostroumova O., Kulikova M.
Uncontrolled arterial hypertension: main causes, features of pathogenesis and approaches to treatment
Denisova A., Solntseva T., Sivakova O., Chazova I.
Uncontrolled arterial hypertension in patients with breast cancer and the risk of developing cardiotoxicity with anthracycline-containing chemotherapy
Oshchepkova E., Avalyan A., Rogoza A., Gorieva S., Saidova M., Chazova I.
Rekomendatsii ESH/ESC 2013 g. po lecheniyu arterial'noy gipertonii
Mancia G., Fagard R.
Clinical features and course of arterial hypertension in patients with its various forms
Denisova A., Esaulova T., Solntseva T., Sivakova O., Chazova I.
Resistant and refractory arterial hypertension: similarities and differences, new approaches to diagnosis and treatment
Aksenova A., Esaulova T., Sivakova O., Chazova I.
Primary hyperaldosteronism as a possible cause of resistant arterial hypertension
Chikhladze N.
Diagnosis and treatment of arterial hypertension [Guidelines]
Chazova I., Zhernakova Y.
Features of antihypertensive and vasoprotective efficiency of combination of valsartan and amlodipine in patients with obesity under different polymorphic variants of CYP2C9 and CYP11B2 genes
Kovalenko F., Skibitsky V., Fendrikova A.
Guidelines for diagnostics and treatment of hypertension 2018 - European experts’opinion [Guidelines]
Chazova I., Zhernakova Y.
The efficacy and safety of torasemid in the treatment of arterial hypertension in different clinical situations
Ostroumova O., Piksina G., Smolyarchuk E., Pavleeva E., Bondarets O.
Advantages azilsartan medoxomil in patients with arterial hypertension: how to make a choice and to optimize antihypertensive therapy?
Martynyuk T., Chazova I.
The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide
Ostroumova O., Garelik I., Karavashkina E.
The possibility of a new receptor blocker to angiotensin in improving control of hypertension. Non-intervention international multicenter observational prospective study of the use azilsartan medoxomil in patients with arterial hypertension and overweight or obesity in the Russian Federation and the Republic of Kazakhstan
Zhernakova Y., Chazova I.
Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach
Zhernakova Y., Sharipova G., Chazova I.
The application of torasemide in patients with arterial hypertension: evidence-based and practical approaches
Gilyarevsky S., Kuzmina I., Golshmid M.
Methods of sympathetic activity evaluation in patients with systemic refractory hypertension
Grigin V., Danilov N., Sagaydak O., Shelkova G., Chazova I.
Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders
Zhernakova Y., Chazova I.
Hypertension treatment features in perimenopausal women
Zhernakova Y., Chazova I.
Antihypertensive efficacy of a fixed full-dose perindopril A-indapamide combination in patients with grades 2–3 arterial hypertension
Glukhova T., Solgalova S., Alferov V.
Kombinirovannaya terapiya ingibitorom angiotenzinprevrashchayushchego fermenta i diuretikom
Chazova I., Martynyuk T.
Vozmozhnosti korrektsii endotelial'noy disfunktsii ingibitorami angiotenzinprevrashchayushchego fermenta
Gorokhovskaya G., Petina M., Akatova E., Aksenov I., Martynov A.
Gipertonicheskie krizy, sovremennye printsipy terapii
Tereshchenko S.
Ot idei k klinicheskoy praktike: pervye rezul'taty Rossiyskogo natsional'nogo issledovaniya optimal'nogo snizheniya arterial'nogo davleniya (ROSA)
Chazova I., Belenkov Y.
Povyshenie arterial'nogo davleniya i gipotenzivnaya terapiya pri insul'te
Parfenov V.
Efficacy and safety of using a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients with diabetes mellitus
Zhernakova J., Chazova I.
Speckle-tracking echocardiography in 3D mode in assessing the deformation of the myocardium and identifying subclinical cardiotoxicity during chemotherapy in breast cancer patients with arterial hypertension
Avalyan A., Saidova M., Oshchepkova E., Chazova I.
The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus
Zhernakova J., Chazova I., Blinova N.
Arterial hypertension in the elderly and higher mental functions. Possibilities of an-tihypertensive therapy withArifon retard in the prevention of dementia.
Ostroumova O., Korsakova N., Varako N.
Radiofrequency renal denervation with different device for treatment in patient with uncontrolled hypertension
Agaeva R., Danilov N., Shelkova G., Sagaydak O., Grigin V., Matchin U., Chazova I.
Blood pressure level and arterial stiffness parameters role in prediction of the antihypertensive therapy efficacy escape phenomenon
Mikhailova O., Elfimova E., Litvin A., Rogoza A.
Dynamics of clinico-psychological characteristics in patients with obstructive sleep apnea syndrome and arterial hypertension after one month of the use of CPAP therapy
Konovalova K., Elfimova E., Mikhailova O., Fedorova V., Litvin A.
Clinical efficacy of sympathetic denervation of renal arteries in patients with resistant arterial hypertension as part of annual prospective follow-up
Gapon L., Mikova E., Savelyeva N., Kolunin G., Zherzhova A.
Prolonged release verapamil: application in clinical practice
Gaponova N., Abdrakhmanov V.
The major arteries and skin microcirculatory vessels status and antihypertensive therapy effect on them in hypertensive patients with high and very high cardiovascular risk
Mordvinova E., Oshchepkova E., Fedorovich A., Zairova A., Pogorelova O., Tripoten M., Rogoza A.
The prevalence of renal dysfunction in arterial hypertension (in the framework of the ESSE-RF study)
Oshchepkova E., Dolgusheva I., Zhernakova I., Chazova I., Shal'nova S., Iarovaia E., Rotar' O., Konradi A., Boitsov S.
Effectiveness and safety of indapamide sustained-release in the treatment of post partial hypertension
Gaisin I., Iskchakova A., Shilina L., Maksimov N., Vavilkina Z., Sava N.
Dynamics of arterial hypertension and its impact on mortality in the Russian population
Balanova Y., Shalnova S., Deyev A., Konstantinov V., Kapustina A.
Experience of treating hypertension in an outpatient setting: a clinical case
Agafonov A., Khozyainova N., Petruschenkova O.
Coagulogic risk factors of heart disease in the adult population of Tomsk
Dobrovolsky A., Titaeva E., Yarovaya E., Storozhilova A., Zhernakova Y., Oschepkova E., Panchenko E., Trubacheva I., Serebryakova V., Kaveshnikova V., Chazova I., Karpov R.
Primenenie diuretikov u bol'nykh arterial'noy gipertoniey s metabolicheskimi narusheniyami
Zhernakova Y., Chazova I.
Evaluation of the antihypertensive efficacy and safety of moxonidine in the treatment of uncomplicated hypertensive crisis
Tereshchenko S., Gaponova N., Abdrakhmanov V.
Primenenie ingibitorov angiotenzinprevrashchayushchego fermenta v lechenii arterial'noy gipertonii
Galyavich A.
Effektivnost' i bezopasnost' sovremennykh mochegonnykh preparatov u patsientov s arterial'noy gipertoniey oslozhnennogo techeniya
Chazova I.
Otsenka effektivnosti moeksiprila u bol'nykh myagkoy i umerennoy arterial'noy gipertoniey s gipertrofiey miokarda levogo zheludochka (issledovanie ENIGMA)
Belenkov Y., Chazova I., Ratova L., Ataullakhanova D., Karpov R., Shlyakhto E., Fomin I.
Rossiyskoe mnogotsentrovoe issledovanie FAGOT (farmakoekonomicheskaya otsenka ispol'zovaniya ingibitorov angiotenzinprevrashchayushchego fermenta v ambulatornom lechenii bol'nykh arterial'noy gipertoniey oslozhnennogo techeniya)
Chazova I.
Vozmozhnosti obespecheniya nefroprotektsii na fone blokady retseptorov angiotenzina II kandesartanom u bol'nykh arterial'noy gipertoniey
Chikhladze N., Chazova I.
Comparative characteristics of indicators of peripheral arterial and central aortic pressure, remodeling of the left ventricular myocardium in salt-sensitive and salt-resistant patients with arterial hypertension
Skibitskiy V., Vasil'ev V., Fendrikova A., Pyatakov S.
The place of fixed antihypertensive drugs in modern therapy of arterial hypertension
Pinchuk T., Orlova N.
Features of cerebral autoregulation and reactivity in patients with arterial hypertension in older age groups with orthostatic hypotensive reactions
Atyunina I., Oshchepkova E., Rogoza A.
Orthostatic reactions and cognitive dysfunctions in elderly and senile patients with arterial hypertension
Atyunina I., Oschepkova E., Rogoza A., Lazareva N.
The condition of parameters of memory, attention and thinking at men of young age officers under the contractwith arterial hypertension.
Davidovich I., Afonaskov O., Staroverova Y.
The relationship between the antihypertensive effect of b-adrenergic blockers and the initial daily variability of sinus rhythm
Sobolev A., Talabanov P., Ryabykina G., Kozhemyakina E.
Arterial hypertension in patients with non-specific aortoarteritis
Chikhladze N.
The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders
Chazova I., Zhernakova Y., Blinova N., Rogoza A.
Dihydropyridine calcium antagonists: conscious choice
Ostroumova O., Vikentev V., Abrosimov A., Smoliarchuk E.
Nephroprotective in patients with metabolic syndrome: approaches to the appointment of antihypertensive drugs
Ostroumova O., Zykova A., Maksimov M.
The role of b-blockers in treatment of hypertension, according to Russian and European experts
Ostroumova O., Fomina V., Shchukina G., Smoliarchuk E.
The results of the pharmacoepidemiological study PIFAGOR IV concerning arterial hypertension (AH patients survey)
Leonova M., Belousov Y., Shteinberg L., Alimova E., Smirnova E., Belousov D.
Heart rate in patients with arterial hypertension:a possible marker of high risk or independent therapeutic target?
Kobalava Z., Shavarova E.
First results of the Russian database of international prospective observational registry variability of blood pressure in patients with hypertension
Ostroumova O.
The functional state of microcirculatory vessels in patients with arterial hypertension I-II degree with different degrees of cardiovascular risk
Mordvinova E., Oschepkova E., Fedorovich A., Rogoza A.
Covremennye predstavleniya ob ideal'noy kombinatsii antigipertenzivnykh preparatov dlya profilaktiki insul'ta
Ostroumova O., Fomina V., Guseva T.
Efficacy of irbesartan in arterial hypertension and metabolic syndrome
Ostroumova O., Zykova A., Polosova T., Bondarets O.
Stress-induced arterial hypertension – clinical features and treatment options
Ratova L., Chazova I.
Pri vsem bogatstve vybora drugoy al'ternativy net Issledovanie ETNA Plyus (ETNA v zhizni vracha polikliniki)
Chazova I., Ratova L.
Primenenie karvedilola u bol'nykh s metabolicheskim sindromom
Mychka V., Chazova I.
Vozmozhnosti primeneniya beta-adrenoblokatorov s vazodilatiruyushchimi svoystvami u bol'nykh arterial'noy gipertoniey
Chikhladze N., Chazova I.
Pervye rezul'taty Rossiyskoy programmy po izucheniyu effektivnosti primeneniya akarbozy u patsientov s narushennoy tolerantnost'yu k glyukoze i arterial'noy gipertoniey (APREL')
Chazova I., Mychka V., Belenkov Y.
Drug therapy of arterial hypertension: assessment of the physicians’ basic knowledge. Final results of the PHYSTARH project
Bontsevich R., Vovk Y., Gavrilova A., Kirichenko A., Krotkova I., Kosmacheva E., Kompaniets O., Prozorova G., Nevzorova V., Martynenko I., Ketova G., Barysheva V., Maksimov M., Osipova O.
Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease
Chazova I., Nevzorova V., Ambatiello L., Brodskaia T., Oshchepkova E., Belevskii A., Zhernakova J., Aisanov Z., Ovcharenko S., Chuchalin A.
First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension
Chazova I., Martynyuk T., Rodnenkov V., Gorieva B., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galiavich A., Rotar’ O., Haisheva L., Kameneva T.
The nature of the course of arterial hypertension in low-renin hyperaldosteronism
Chikhladze N.
Fleita is a Russian randomized, open-label, multicenter, comparative program for the evaluation of the efficacy and safety of the fixed combination drug Tarka (ABBOTT Laboratories, USA) versus optional sustained-release antihypertensive drugs in the treatment of patients with arterial hypertension and cognitive disorders (stepwise strategy)
Chazova I., Ostroumova O.
The role of b-blockers in the new revision of the 2018 European guidelines for the diagnosis and treatment of arterial hypertension in the patients with comorbidities
Ostroumova O., Kochetkov A.
The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results
Zhernakova Y., Chazova I., Oshchepkova E., Shalnova S., Konradi A., Rotar O., Yarovaya E., Shlyahto E., Boitsov S.
Markers of early cardiotoxicity in patients with breast cancer undergoing chemotherapy depending on blood pressure level
Avalyan A., Kirillova M., Shitov V., Oshchepkova Y., Saidova M., Stenina M., Chazova I.
Quality assessment of examination of patients with arterial hypertension in primary health care (according to the Russian arterial hypertension register data)
Oshchepkova E., Lazareva N., Chazova I.
Radiofrequency renal arteries denervation: effectively and safely
Grigin V., Danilov N., Matchin Y., Chazova I.
Effectiveness of combined antihypertensive treatment depending on the phenomenon of salt sensitivity in patients with refractory arterial hypertension
Skibitskiy V., Garkusha E., Fendrikova A.
The efficacy offixed combination of bisoprolol and amlodipine in patients with arterial hypertension, ischemic heart disease and metabolic syndrome
Skibickiy V., Fendrikova A., Skibickiy A., Syrotenko D.
The role of the vegetative part of sympathetic nervous system in development of cardiovascular complications in patients with arterial hypertension: pharmacological aspects
Gilyarevsky S.
The benefits of candesartan usage in the treatment of arterial hypertension
Ostroumova O., Bondarets O., Guseva T.
The telmisartan and amlodipine combination in the treatment of hypertension
Shehyan G., Yalymov A., Schikota A., Zadionchenko V., Varentsov S.
Izuchenie kognitivnykh funktsiy mozga u bol'nykh arterial'noy gipertoniey s nalichiem ili otsutstviem metabolicheskogo sindroma
Sharipova G., Chazova I., Zhernakova Y.
Blokatory kal'tsievykh kanalov III pokoleniya pri lechenii arterial'noy gipertonii
Shilov A.
The diagnosis and treatment of patients with arterial hypertension and chronic obstructive inflammatory pulmonary diseases (Guidelines of the Russian Medical Society on Arterial Hypertension and the Russian Respiratory Society)
Chazova I., Chuchalin A., Zykov K., Ratova L.
Effektivnoe i bezopasnoe ispol'zovanie perindoprila v doze 8 mg v kachestve startovogo lecheniya bol'nykh arterial'noy gipertoniey v usloviyakh statsionara (po rezul'tatam issledovaniya DOMINANTA)
Ostroumova O., Barabash O., Bondareva Z., Yakhontov D., Pereskal'skaya M., Mordvinova N., Paukov S.
Osnovnye rezul'taty programmy APREL'
Chazova I., Mychka V., Belenkov Y.
Vliyanie terapii bisoprololom i aktoveginom na perfuziyu golovnogo mozga u patsientov s metabolicheskim sindromom
Mychka V., Chazova I., Gornostaev V., Sergienko V.
Arterial'naya gipertoniya i ishemicheskaya bolezn' serdtsa: poisk optimal'nykh podkhodov k lecheniyu (po rezul'tatam issledovaniya INVEST)
Chazova I.
Consensus of experts from the Russian Medical Society of Arterial Hypertension. Arterial hypertension and erectile dysfunction
Alekseeva T., Litvin A., Elfimova E., Mikhailova O., Larina V., Shpot E., Podzolkov V., Chazova I.
Renal artery denervation in patients with resistant arterial hypertension: clinical and organ-protective effect
Gapon L., Mikova E., Krinochkin D., Savelyeva N., Zherzhova A., Aleksandrovich E.
Radiofrequency renal denervation with mono-electrode and multi-electrode device for treatment in patient with uncontrolled hypertension: results of a 6-month follow-up
Agaeva R., Danilov N., Shchcelkova G., Matchin Y., Chazova I.
Rationale for the use of sartans in patients with arterial hypertension
Stryuk R.
Features of diurnal blood pressure profile, arterial stiffness and left ventricular structure and function in patients with arterial hypertension, prediabetes and type 2 diabetes mellitus
Fendrikova A., Gutova S., Skibitsky V., Skibitsky A.
The influence of antyhypertensive therapy of valsartan and fixed combination with hydrochlorothiazide use on pulse-wave velocity and central arterial pressure in patients with arterial hypertension of 1-2 grades in international VICTORY clinical trial
Chazova I., Martynyuk T., Accetto R., Sirenko Y., Vincelj J., Widimsky J., Barbič-Žagar B., Arhipov M., Grinshtein Y., Ostroumova O., Galjavich A., Rotar O., Haisheva L., Nedogoda S.
Modern concepts of the relationship between obesity and erectile dysfunction in patients with arterial hypertension
Alekseeva T., Litvin A.
1 - 100 的 179 信息 1 2 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##